$3,500.00
GBI Research, a leading business intelligence provider, has released its latest research, “Women’s Health Therapeutics Market to 2018 - Unmet Need for Safe and Effective Treatments due to Unfavorable .....
Published: Nov-2012
|
$3,500.00
The leading business intelligence provider GBI Research has released its latest research, “Contraceptives Market to 2018 – Safety Concerns Plague Drospirenone-containing Birth Control Pills and Long-t.....
Published: Nov-2012
|
$3,500.00
GBI Research, a leading business intelligence provider, has released its latest research “Women’s Health Therapeutics Market to 2017 - High Unmet Need will Drive Uptake of Novel Drugs Such as Prolia a.....
Published: Jan-2012
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research, “Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future” .....
Published: Oct-2011
|
$3,500.00
GBI Research, the leading business intelligence provider, has released its latest research “Contraceptive Market to 2016 Demand for Long Acting Birth Control Pills Encourages Growth in Hormonal Contra.....
Published: Dec-2010
|
$3,500.00
GBI Research’s report, “The Women's Health Therapeutics Market to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in Menopause and Osteoporosis”, provides in-depth analysis of unmet needs,.....
Published: Jul-2010
|